Background—Our purpose was to describe a 13-year experience with patients undergoing
transcatheter device closure of unrepaired congenital or postoperative residual ventricular …

Background Post‐myocardial infarction (MI) ventricular septal defects (PIVSD) are an
uncommon but life‐threatening complication of acute MI. Although surgical closure has been …

The management of congenital heart disease has changed dramatically over the last 15
years and continues to evolve at a rapid pace. More than ever before contemporary practice …

Aim To report the experience of 23 tertiary referral European Centres on transcatheter
closure of congenital ventricular septal defects (VSD). Methods and results Implantation of …

Objectives: We sought to analyze safety, efficacy, and follow-up results of percutaneous
closure of perimembranous ventricular septal defects (pmVSD). Background: Results of …

Aims Immediate surgical repair of ventricular septal defect (VSD) complicating acute
myocardial infarction is associated with high mortality. Percutaneous device closure appears …

Objectives: We sought to report the results of a US registry of device closure of congenital
muscular ventricular septal defects (VSDs) using the new Amplatzer mVSD occluder (AGA …

The objective of this study was to assess the immediate and mid‐term results of
transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new …

This study reports on experience with transcatheter closure of congenital ventricular septal
defects (VSDs) with Amplatzer septal occluders. From January 2000 to April 2005 …

Hybrid procedures are becoming increasingly important, especially in the management of
congenital heart lesions for which there are no ideal surgical or interventional options. This …